Transplantation of two populations of stem cells to improve engraftment: WO2008060932

Expert Opinion on Therapeutic Patents

Volumn 20, Issue 9, 2010, Pages 1259-1263

  Taupin, Philippe ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

Bone marrow; Cellular therapy; Cord blood; Intravenous; Reticuloendothelial system

Indexed keywords

ALLOTRANSPLANTATION; ARTICLE; CORD BLOOD STEM CELL TRANSPLANTATION; ENGRAFTMENT; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; MYELOABLATIVE CONDITIONING; NEUTROPHIL; OUTCOME ASSESSMENT; TREATMENT INDICATION; UMBILICAL CORD BLOOD;

BLOOD PLATELETS; CORD BLOOD STEM CELL TRANSPLANTATION; HEMATOLOGIC DISEASES; HUMANS; MYELOABLATIVE AGONISTS; NEUTROPHILS; PATENTS AS TOPIC; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 77955811468     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.2010.495123     Document Type: Article

References (29)

1. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996;335:157-166
2. Cohen Y, Nagler A. Umbilical cord blood transplantation: how, when and for whom? Blood Rev 2004;18:167-179
3. Thomas ED. History, current results, and research in marrow transplantation. Perspect Biol Med 1995;38:230-237
4. Wang JC, Doedens M, Dick JE. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood 1997;89:3919-3924
5. Taupin P. OTI-010 Osiris Therapeutics/ JCR Pharmaceuticals. Curr Opin Investig Drugs 2006;7:473-481
6. Rocha V, Labopin M, Sanz G, et al. Transplants of umbilical cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004;351:2276-2285
7. Takahashi S, Iseki T, Ooi J, et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood 2004;104:3813-3820
8. Gluckman E, Rocha V, Arcese W, et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004;32:397-407
9. Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001;344:1815-1822
10. Long GD, Laughlin M, Madan B, et al. Unrelated umbilical cord blood transplantation in adult patients. Biol Blood Marrow Transplant 2003;9:772-780
11. Szabolcs P, Niedzwiecki D. Immune reconstitution after unrelated cord blood transplantation. Cytotherapy 2007;9:111-122
12. Kurtzberg J, Prasad VK, Carter SL, et al. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood 2008;112:4318-4327
13. De Lima M, St John LS, Wieder ED, et al. Double-chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units. Br J Haematol 2002;119:773-776
14. Barker JN, Wagner JE. Umbilical cord blood transplantation: current practice and future innovations. Crit Rev Oncol Hematol 2003;48:35-43
15. Piacibello W, Sanavio F, Severino A, et al. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. Blood 1999;93:3736-3749
16. Ballen K, Becker PS, Greiner D, et al. Effect of ex vivo cytokine treatment on human cord blood engraftment in NOD-scid mice. Br J Haematol 2000;108:629-640
17. Xia L, McDaniel JM, Yago T, et al. Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow. Blood 2004;104:3091-3096
18. McNiece IK, Almeida-Porada G, Shpall EJ, et al. Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential. Exp Hematol 2002;30:612-616
19. Hidalgo A, Frenette PS. Enforced fucosylation of neonatal CD34+ cells generates selectin ligands that enhance the initial interactions with microvessels but not homing to bone marrow. Blood 2005;105:567-575
20. Taupin P. Ex vivo fucosylation to improve the engraftment capability and therapeutic potential of human cord blood stem cells. Drug Discov Today 2010; In press
21. Brouwer A, Knook DL. The reticuloendothelial system and aging: a review. Mech Ageing Dev 1983;21:205-228
22. Shpall EJ, Quinones R, Giller R, et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002;8:368-376
23. Fernandez MN, Regidor C, Cabrera R, et al. Unrelated umbilical cord blood transplants in adults: early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34+ cells from an HLA-haploidentical donor. Exp Hematol 2003;31:535-544
24. Brown AB, Yang W, Schmidt NO, et al. Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. Hum Gene Ther 2003;14:1777-1785
25. Pluchino S, Quattrini A, Brambilla E, et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 2003;422:688-694
26. Taupin P. The therapeutic potential of adult neural stem cells. Curr Opin Mol Ther 2006;8:225-231 (Pubitemid 43852768)
27. Rice CM, Mallam EA, Whone AL, et al. Safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis. Clin Pharmacol Ther 2010; In press
28. Wang J, Zhang S, Rabinovich B, et al. Human CD34+ cells in experimental myocardial infarction. Long-term survival, sustained functional improvement, and mechanism of action. Circ Res 2010; In press
29. Title: Methods for improved engraftment following stem cell transplantation Assignee: Aldagen, Inc. Inventor: Balber AE Priority data: 08/11/2006 Filing date: 08/11/2007 Publication date: 22/05/2008 Publication no.: WO2008060932